H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

H.B. Fuller Company

In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Sell rating on Fulcrum Therapeutics, with a price target of $...

Bank of America Securities Sticks to Their Sell Rating for Fulcrum Therapeutics (FULC)

An update from Fulcrum Lithium Ltd. ( ($AU:FUL) ) is now available. Fulcrum Lithium has released a corporate investor presentation centred on a mai...

Fulcrum Lithium Highlights Maiden Alkali Flats Resource in Investor Presentation

In a report released today, Gregory Renza from Truist Financial maintained a Hold rating on Fulcrum Therapeutics, with a price target of $4.00. Acc...

Fulcrum Therapeutics (FULC) Gets a Hold from Truist Financial

KBW analyst David Konrad reiterated a Hold rating on Fulton Financial today and set a price target of $26.00. According to TipRanks, Konrad is a 5-...

KBW Sticks to Their Hold Rating for Fulton Financial (FULT)

Insiders have been trading these 5 stocks: (($FRMM)), (($BYRN)), (($GREE)), (($FULC)) and (($ZNB)). Here is a breakdown of their recent trades and ...

Forum Markets, Byrna, Greenidge, Fulcrum, Zeta Insider Shocks

Fulton Financial (($FULT)) has held its Q2 earnings call. Read on for the main highlights of the call. Fulton Financial’s latest earnings call stru...

Fulton Financial Leverages Acquisition to Lift Earnings

An announcement from H.B. Fuller Company ( ($FUL) ) is now available. On July 17, 2026, H.B. Fuller Company amended its existing credit agreement w...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FUL	$62.75	+4.32%	859.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FUL	$62.75	+4.3%	859.47K
3
4
5
6

FUL

Get H.B. Fuller Company Data in Excel

Get H.B. Fuller Company Data in Excel